Zymergen Investor Relations Material
Latest events
Status Update
Zymergen
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Zymergen Inc
Access all reports
Zymergen Inc. designs, develops, and commercializes microbes, molecules, and materials for research in the life sciences. It offers a solution that automates biology experiments; a suite of software tools for automation of plants and facilities; hardware components comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; automation control software; and integrated automation systems with parts and services. The company also provides reagent bottles and automated dispensing systems, as well as small molecule screening and process development platform comprising single cell engineered microorganisms with tool kits for analysis. In addition, it offers consulting and advisory services comprising process design to manufacturing services using its solutions for process development, strain engineering, microbial characterization, culture media development, fermentor vessel design and validation services.
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
ZY
Country
🇺🇸 United States